Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps2-17-05 | Thyroid Cancer Diagnosis 2 | ETA2023

18F-DOPA-PET/ct in medullary thyroid cancer patients with biochemical incomplete response

Gambale Carla , Faranda Alessio , Prete Alessandro , Minaldi Elisa , Cappagli Virginia , Ambrogio Alice , Volterrani Duccio , Elisei Rossella , Matrone Antonio

Objectives: PET/CT scan with 18F-fluoro-dihydroxyphenylalanine (18F-DOPA) is an emerging useful tool in medullary thyroid cancer (MTC) patients. The question whether 18F-DOPA-PET/CT could be useful in MTC patients with biochemical incomplete response (BiR) is to clarify.Methods: Fifty-three MTC patients with BiR performed 18F-DOPA-PET/CT scan between May 2021 and December 2022 after having performed total body ...